We have located links that may give you full text access.
Creation of a Patient-Specific Total Hip Arthroplasty Periprosthetic Fracture Risk Calculator.
Journal of Arthroplasty 2023 March 17
BACKGROUND: Many risk factors have been described for periprosthetic femur fracture (PPFFx) following total hip arthroplasty (THA), yet a patient-specific risk assessment tool remains elusive. The purpose of this study was to develop a high-dimensional, patient-specific risk-stratification nomogram that allows dynamic risk modification based on operative decisions.
METHODS: We evaluated 16,696 primary non-oncologic THAs performed between 1998 and 2018. During mean 6-year follow-up, 558 patients (3.3%) sustained PPFFx. Patients were characterized by individual natural language processing-assisted chart review on non-modifiable factors (demographics, THA indication, comorbidities), and modifiable operative decisions (femoral fixation [cemented/uncemented], surgical approach [direct anterior, lateral, posterior], implant type [collared/collarless]). Multivariable Cox regression models and nomograms were developed with PPFFx as a binary outcome at 90-days, 1-year, and 5-years postoperatively.
RESULTS: Patient-specific PPFFx risk based on comorbid profile was wide-ranging from 0.4-18% at 90-days, 0.4-20% at 1-year, and 0.5-25% at 5-years. Among 18 evaluated patient factors, 7 were retained in multivariable analyses. The 4 significant non-modifiable factors included: women (Hazard Ratio (HR)=1.6), older age (HR=1.2 per 10 years), diagnosis of osteoporosis or use of osteoporosis medications (HR=1.7), and indication for surgery other than osteoarthritis (HR=2.2 for fracture, HR=1.8 for inflammatory arthritis, HR=1.7 for osteonecrosis). The 3 modifiable surgical factors were included: uncemented femoral fixation (HR=2.5), collarless femoral implants (HR=1.3), and surgical approach other than direct anterior (lateral HR=2.9, posterior HR=1.9).
CONCLUSION: This patient-specific PPFFx risk calculator demonstrated a wide-ranging risk based on comorbid profile and enables surgeons to quantify risk mitigation based on operative decisions.
METHODS: We evaluated 16,696 primary non-oncologic THAs performed between 1998 and 2018. During mean 6-year follow-up, 558 patients (3.3%) sustained PPFFx. Patients were characterized by individual natural language processing-assisted chart review on non-modifiable factors (demographics, THA indication, comorbidities), and modifiable operative decisions (femoral fixation [cemented/uncemented], surgical approach [direct anterior, lateral, posterior], implant type [collared/collarless]). Multivariable Cox regression models and nomograms were developed with PPFFx as a binary outcome at 90-days, 1-year, and 5-years postoperatively.
RESULTS: Patient-specific PPFFx risk based on comorbid profile was wide-ranging from 0.4-18% at 90-days, 0.4-20% at 1-year, and 0.5-25% at 5-years. Among 18 evaluated patient factors, 7 were retained in multivariable analyses. The 4 significant non-modifiable factors included: women (Hazard Ratio (HR)=1.6), older age (HR=1.2 per 10 years), diagnosis of osteoporosis or use of osteoporosis medications (HR=1.7), and indication for surgery other than osteoarthritis (HR=2.2 for fracture, HR=1.8 for inflammatory arthritis, HR=1.7 for osteonecrosis). The 3 modifiable surgical factors were included: uncemented femoral fixation (HR=2.5), collarless femoral implants (HR=1.3), and surgical approach other than direct anterior (lateral HR=2.9, posterior HR=1.9).
CONCLUSION: This patient-specific PPFFx risk calculator demonstrated a wide-ranging risk based on comorbid profile and enables surgeons to quantify risk mitigation based on operative decisions.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app